• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Industry-Academia Collaboration in the Clinical Laboratory Field: Chairmen's Introductory Remarks].

作者信息

Inaba Tohru, Ikemoto Toshiyuki

出版信息

Rinsho Byori. 2016 Jan;64(1):99-100.

PMID:27192804
Abstract

Industry-academia collaboration has become essential in contemporary medicine. Therefore, many institutes including university corporations have promoted the establishment of an endowed chair and/or performed collaborative research. This symposium was held to overview the present status of industry-academia collaboration in the clinical laboratory field. As a representative of the industry, Mr. Taniguchi (Sysmex) presented the development process of M2BP Glycosylation Isomer, a new marker for liver fibrosis. Mr. Saitoh (Horiba) introduced the achievements of joint collaborative research with Kyoto Prefectural University of Medicine, especially the practical realization of an automated hematology analyzer capable of simultaneously measuring C-reactive protein. Mr. Setoyama (LSI Medience) presented on the characteristic collaboration between academia and commercial laboratories such as Tsukuba Medical Laboratory of Education and Research (TMER). On the other hand, as a representative of academia, Associate Prof. Imai (Kyoto Prefectural University of Medicine) summarized the necessity of clinical laboratories spread regenerative medicine. Finally, Prof. Koshiba (Hyogo College of Medicine) presented on the industry-academia collaboration in routine laboratory work in his institute.

摘要

相似文献

1
[Industry-Academia Collaboration in the Clinical Laboratory Field: Chairmen's Introductory Remarks].
Rinsho Byori. 2016 Jan;64(1):99-100.
2
["How can hospitals develop a beneficial relationship with laboratory testing companies?" - Chairmen's introductory remarks].["医院如何与检验检测公司建立互利关系?——主席开场白"]
Rinsho Byori. 2014 Dec;62(12):1245-6.
3
[Signs can be Found in "Clinical Laboratory Values" and "Ultrasonographic Findings" -Chairmen's Introductory Remarks.].[体征可见于“临床实验室检查值”和“超声检查结果”——主席引言。]
Rinsho Byori. 2016 May;64(4):453-454.
4
[Practice and Role of Team Approach to Medicine in Clinical Laboratory Medicine--Chairmen's Introductory Remarks].[团队医疗模式在临床检验医学中的实践与作用——主席引言]
Rinsho Byori. 2015 Jul;63(7):844-5.
5
[What Should We Do in the Department of Clinical Laboratory in the Future?--Chairmen's Introductory Remarks].[未来临床检验科室该如何发展?——主席开场白]
Rinsho Byori. 2014 Oct;62(10):986-7.
6
[Chairmen's Introductory Remarks].[主席的开场白]
Rinsho Byori. 2017 Jan;65(1):81-82.
7
[Chairmen's Introductory Remarks].[主席的开场白]
Rinsho Byori. 2016 Aug;64(8):895-897.
8
[Experience of Collaborative Research through Department of Medical Instrumental Research and Technology in Kyoto Prefectural University of Medicine].[京都府立医科大学医学仪器研究与技术系的合作研究经验]
Rinsho Byori. 2016 Jan;64(1):102-6.
9
[Development of novel laboratory technology--Chairmen's introductory remarks].
Rinsho Byori. 2012 Jul;60(7):627-9.
10
[Issues Associated with the Management of Clinical Laboratories and Their Future: What is the Problem in Our Laboratory?--Chairmen's Introductory Remarks].[临床实验室管理相关问题及其未来:我们实验室存在什么问题?——主席引言]
Rinsho Byori. 2015 Mar;63(3):397-9.